Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections

Saman Nematollahi; Shmuel Shoham

doi:10.1007/s12281-019-00364-4

Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections

Saman Nematollahi, Shmuel Shoham

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Purpose of Review: This review summarizes both the recent and relevant studies about the treatment of non-Aspergillus hyaline molds. Recent Findings: Given the rarity of these infections, there have been no large randomized clinical trials regarding the most effective antifungal therapy. Summary: Although there are more data for the treatment of Fusarium and Scedosporium, there are limited data with case reports that address the other rare hyalohyphomycetes. As we develop improved diagnostic techniques and larger fungal registries, we may be able to determine efficacious treatment modalities. We hope that future research will focus on implementing clinical trials with the new antifungals and ongoing development of novel fungal agents.

Original language	English (US)
Pages (from-to)	308-319
Number of pages	12
Journal	Current Fungal Infection Reports
Volume	13
Issue number	4
DOIs	https://doi.org/10.1007/s12281-019-00364-4
State	Published - Dec 1 2019

Keywords

Antifungal therapy
Emerging fungal infections
Fusarium
Hyaline molds
Hyalohyphomycetes
Scedosporium

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1007/s12281-019-00364-4

Cite this

@article{b0e9524176bd42c5acac68ea9f4bf1b2,

title = "Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections",

abstract = "Purpose of Review: This review summarizes both the recent and relevant studies about the treatment of non-Aspergillus hyaline molds. Recent Findings: Given the rarity of these infections, there have been no large randomized clinical trials regarding the most effective antifungal therapy. Summary: Although there are more data for the treatment of Fusarium and Scedosporium, there are limited data with case reports that address the other rare hyalohyphomycetes. As we develop improved diagnostic techniques and larger fungal registries, we may be able to determine efficacious treatment modalities. We hope that future research will focus on implementing clinical trials with the new antifungals and ongoing development of novel fungal agents.",

keywords = "Antifungal therapy, Emerging fungal infections, Fusarium, Hyaline molds, Hyalohyphomycetes, Scedosporium",

author = "Saman Nematollahi and Shmuel Shoham",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2019",

month = dec,

day = "1",

doi = "10.1007/s12281-019-00364-4",

language = "English (US)",

volume = "13",

pages = "308--319",

journal = "Current Fungal Infection Reports",

issn = "1936-3761",

publisher = "Current Science, Inc.",

number = "4",

}

TY - JOUR

T1 - Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections

AU - Nematollahi, Saman

AU - Shoham, Shmuel

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Purpose of Review: This review summarizes both the recent and relevant studies about the treatment of non-Aspergillus hyaline molds. Recent Findings: Given the rarity of these infections, there have been no large randomized clinical trials regarding the most effective antifungal therapy. Summary: Although there are more data for the treatment of Fusarium and Scedosporium, there are limited data with case reports that address the other rare hyalohyphomycetes. As we develop improved diagnostic techniques and larger fungal registries, we may be able to determine efficacious treatment modalities. We hope that future research will focus on implementing clinical trials with the new antifungals and ongoing development of novel fungal agents.

AB - Purpose of Review: This review summarizes both the recent and relevant studies about the treatment of non-Aspergillus hyaline molds. Recent Findings: Given the rarity of these infections, there have been no large randomized clinical trials regarding the most effective antifungal therapy. Summary: Although there are more data for the treatment of Fusarium and Scedosporium, there are limited data with case reports that address the other rare hyalohyphomycetes. As we develop improved diagnostic techniques and larger fungal registries, we may be able to determine efficacious treatment modalities. We hope that future research will focus on implementing clinical trials with the new antifungals and ongoing development of novel fungal agents.

KW - Antifungal therapy

KW - Emerging fungal infections

KW - Fusarium

KW - Hyaline molds

KW - Hyalohyphomycetes

KW - Scedosporium

UR - http://www.scopus.com/inward/record.url?scp=85076112705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076112705&partnerID=8YFLogxK

U2 - 10.1007/s12281-019-00364-4

DO - 10.1007/s12281-019-00364-4

M3 - Review article

AN - SCOPUS:85076112705

SN - 1936-3761

VL - 13

SP - 308

EP - 319

JO - Current Fungal Infection Reports

JF - Current Fungal Infection Reports

IS - 4

ER -

Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this